Russia announces free cancer vaccine for citizens by 2025
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free.
Drugs
Pharma
Pharma
Research
Clinical trial of AEF0217 for cognitive function in Down Syndrome shows promise
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial.
Drugs
Pharma
ICER report highlights unsupported price increases of prescription drugs
HQ Team December 13, 2024: The Institute for Clinical and Economic Review (ICER) has released a new report revealing that five high-expenditure drugs.
Drugs
Pharma
AstraZeneca, Merck announce promising results for breast cancer in trial 3
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly.
Drugs
Pharma
Breakthrough in halting dementia progression found by biotech company
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,.
Drugs
Health
Pharma
1 person contracts genital herpes infection every second in the world
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World.
Drugs
Health
Pharma
Mystery disease spreading in Congo, death toll at 31: WHO says
Thirty-one people, mostly children, have died due to an undiagnosed disease in the Democratic Republic of Congo, the WHO stated
Drugs
Medical
Pharma
AstraZeneca, Daiichi’s trial drug for lung cancer, gets US regulator’s nod
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type.
Drugs
Medical
Pharma
AstraZeneca’s drug gets nod to treat limited-stage cell lung cancer patients
The US regulator has approved AstraZeneca’s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.